DARK FOREST CAPITAL MANAGEMENT LP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 145 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
DARK FOREST CAPITAL MANAGEMENT LP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$644,575
-33.7%
25,228
-25.6%
0.05%
-44.4%
Q2 2023$972,367
+446.1%
33,904
+356.4%
0.09%
+109.3%
Q1 2023$178,049
+1593.3%
7,428
+1098.1%
0.04%
+1333.3%
Q4 2022$10,515620
+61900.0%
0.00%
Q4 2021$0
-100.0%
1
-99.7%
0.00%
-100.0%
Q3 2021$14,0002990.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2023
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders